Close Menu

NEW YORK – Cancer sequencing firm Personalis reported after the close of the market on Tuesday that its second quarter 2019 revenues were up 80 percent year over year.

In its first quarterly earnings report after closing a $140 million initial public offering in June, the company recorded total revenues of $15.8 million compared to $8.8 million in Q2 2018, beating analysts' consensus estimate of $14.9 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.